ASCO 2017: Expert discussion on the latest in prostate cancer

ASCO 2017: Expert discussion on the latest in prostate cancer

ASCO 2020 prostate cancer highlightsПодробнее

ASCO 2020 prostate cancer highlights

Clinical updates for metastatic hormone sensitive prostate cancer at ASCO 2019Подробнее

Clinical updates for metastatic hormone sensitive prostate cancer at ASCO 2019

ASCO 2017: Ask The Prostate Cancer ExpertsПодробнее

ASCO 2017: Ask The Prostate Cancer Experts

Pembrolizumab in MSI-H CRC TumorsПодробнее

Pembrolizumab in MSI-H CRC Tumors

MSI Status and Immunotherapy in Advanced Colorectal CancerПодробнее

MSI Status and Immunotherapy in Advanced Colorectal Cancer

Practice Changers in Advanced Prostate Cancer from ASCO 2017: STAMPEDE, LATITUDE vis-à-vis CHAARTEDПодробнее

Practice Changers in Advanced Prostate Cancer from ASCO 2017: STAMPEDE, LATITUDE vis-à-vis CHAARTED

Pazopanib and Sunitinib in Renal Cell CarcinomaПодробнее

Pazopanib and Sunitinib in Renal Cell Carcinoma

ASCO 2017: Following the practice changing results from STAMPEDEПодробнее

ASCO 2017: Following the practice changing results from STAMPEDE

Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatmentПодробнее

Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment